Bepridil reverses atrial electrical remodeling and L-type calcium channel downregulation in a canine model of persistent atrial tachycardia

Journal of Cardiovascular Electrophysiology

Volumn 18, Issue 7, 2007, Pages 765-772

  Nishida, Kunihiro ^a   Fujiki, Akira ^a   Sakamoto, Tamotsu ^a   Iwamoto, Jotaro ^a   Mizumaki, Koichi ^a   Hashimoto, Norio ^b   Inoue, Hiroshi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b NISSAN CHEMICAL INDUSTRIES LTD   (Japan)

Author keywords

Antiarrhythmic agents; Arrhythmia (mechanisms); Ca channel; Remodeling

Indexed keywords

BEPRIDIL; CALCIUM CHANNEL L TYPE; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATRIOVENTRICULAR BLOCK; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE DURATION; DOG; DOWN REGULATION; GENE EXPRESSION; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; NONHUMAN; PRIORITY JOURNAL; REFRACTORY PERIOD; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPRAVENTRICULAR TACHYCARDIA;

ANIMALS; ATRIAL FUNCTION; BEPRIDIL; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; DISEASE MODELS, ANIMAL; DOGS; DOWN-REGULATION; RNA, MESSENGER; TACHYCARDIA, ECTOPIC ATRIAL; UP-REGULATION;

EID: 34250621663     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2007.00833.x     Document Type: Article

References (37)

1. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA: Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995 92: 1954 1968.
2. Yue L, Feng J, Gaspo R, Li GR, Wang Z, Nattel S: Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation. Circ Res 1997 81: 512 525.
3. Brundel BJ, van Gelder IC, Henning RH, Tuinenburg AE, Deelman LE, Tieleman RG, Grandjean JG, van Gilst WH, Crijns HJ: Gene expression of proteins influencing the calcium homeostasis in patients with persistent and paroxysmal atrial fibrillation. Cardiovasc Res 1999 42: 443 454.
4. Goette A, Honeycutt C, Langberg JJ: Electrical remodeling in atrial fibrillation. Time course and mechanisms. Circulation 1996 94: 2968 2974.
5. Ausma J, Dispersyn GD, Duimel H, Thone F, Ver Donck L, Allessie MA, Borgers M: Changes in ultrastructural calcium distribution in goat atria during atrial fibrillation. J Mol Cell Cardiol 2000 32: 355 364.
6. Sun H, Chartier D, Leblanc N, Nattel S: Intracellular calcium changes and tachycardia-induced contractile dysfunction in canine atrial myocytes. Cardiovasc Res 2001 49: 751 761.
7. Fareh S, Benardeau A, Thibault B, Nattel S: The T-type Ca2+ channel blocker mibefradil prevents the development of a substrate for atrial fibrillation by tachycardia-induced atrial remodeling in dogs. Circulation 1999 100: 2191 2197.
8. Fareh S, Benardeau A, Nattel S: Differential efficacy of L- and T-type calcium channel blockers in preventing tachycardia-induced atrial remodeling in dogs. Cardiovasc Res 2001 49: 762 770.
9. Shinagawa K, Shiroshita-Takeshita A, Schram G, Nattel S: Effects of antiarrhythmic drugs on fibrillation in the remodeled atrium: Insights into the mechanism of the superior efficacy of amiodarone. Circulation 2003 107: 1440 1406.
10. Ashikaga K, Kobayashi T, Kimura M, Owada S, Sasaki S, Iwasa A, Furukawa K, Motomura S, Okumura K: Effects of amiodarone on electrical and structural remodeling induced in a canine rapid pacing-induced persistent atrial fibrillation model. Eur J Pharmacol 2006 536: 148 153.
11. Ohashi N, Mitamura H, Tanimoto K, Fukuda Y, Kinebuchi O, Kurita Y, Shiroshita-Takeshita A, Miyoshi S, Hara M, Takatsuki S, Ogawa S: A comparison between calcium channel blocking drugs with different potencies for T- and L-type channels in preventing atrial electrical remodeling. J Cardiovasc Pharmacol 2004 44: 386 392.
12. Shiroshita-Takeshita A, Schram G, Lavoie J, Nattel S: Effect of simvastatin and antioxidant vitamins on atrial fibrillation promotion by atrial-tachycardia remodeling in dogs. Circulation 2004 110: 2313 2319.
13. Shiroshita-Takeshita A, Brundel BJ, Lavoie J, Nattel S: Prednisone prevents atrial fibrillation promotion by atrial tachycardia remodeling in dogs. Cardiovasc Res 2006 69: 865 875.
14. Wang JC, Kiyosue T, Kiriyama K, Arita M: Bepridil differentially inhibits two delayed rectifier K+ currents, IKr and IKs, in guinea-pig ventricular myocytes. Br J Pharmacol 1999 128: 1733 1738.
15. Kobayashi S, Reien Y, Ogura T, Saito T, Masuda Y, Nakaya H: Inhibitory effect of bepridil on hKv1.5 channel current: Comparison with amiodarone and E-4031. Eur J Pharmacol 2001 430: 149 157.
16. Anno T, Furuta T, Itho M, Kodama I, Toyama J, Yamada K: Effects of bepridil on the electrophysiological properties of guinea-pig ventricular muscles. Br J Pharmacol 1984 81: 589 597.
17. Kato R, Singh BN: Effects of bepridil on the electrophysiologic properties of isolated canine and rabbit myocardial fibers. Am Heart J 1986 111: 271 279.
18. Uchino T, Lee TS, Kaku T, Yamashita N, Noguchi T, Ono K: Voltage-dependent and frequency-independent inhibition of recombinant Cav3.2 T-type Ca2+ channel by bepridil. Pharmacology 2005 74: 174 181.
19. Constantin M, Bromont C, Fickat R, Massingham R: Studies on the activity of bepridil as a scavenger of free radicals. Biochem Pharmacol 1990 40: 1615 1622.
20. Fujiki A, Tsuneda T, Sugao M, Mizumaki K, Inoue H: Usefulness and safety of bepridil in converting persistent atrial fibrillation to sinus rhythm. Am J Cardiol 2003 92: 472 475.
21. Fujiki A, Tsuneda T, Sakabe M, Nakagawa K, Mizumaki K, Hirai T, Inoue H: Maintenance of sinus rhythm and recovery of atrial mechanical function after cardioversion with bepridil or in combination with aprindine in long-lasting persistent atrial fibrillation. Circ J 2004 68: 834 839.
22. Nakazato Y, Yasuda M, Sasaki A, Iida Y, Kawano Y, Nakazato K, Tokano T, Mineda Y, Sumiyoshi M, Nakata Y, Daida H: Conversion and maintenance of sinus rhythm by bepridil in patients with persistent atrial fibrillation. Circ J 2005 69: 44 48.
23. Fujiki A, Nagasawa H, Sakabe M, Sakurai K, Nishida K, Mizumaki K, Inoue H: Spectral characteristics of human atrial fibrillation waves of the right atrial free wall with respect to the duration of atrial fibrillation and effect of class I antiarrhythmic drugs. Jpn Circ J 2001 65: 1047 1051.
24. Hara Y, Nakaya H: SD-3212, a new class I and IV antiarrhythmic drug: A potent inhibitor of the muscarinic acetylcholine-receptor-operated potassium current in guinea-pig atrial cells. Br J Pharmacol 1995 116: 2750 2756.
25. Sato T, Costa AD, Saito T, Ogura T, Ishida H, Garlid KD, Nakaya H: Bepridil, an antiarrhythmic drug, opens mitochondrial KATP channels, blocks sarcolemmal KATP channels, and confers cardioprotection. J Pharmacol Exp Ther 2006 316: 182 188.
26. Sato D, Niwano S, Imaki R, Masaki Y, Sasaki S, Yuge M, Hirasawa S, Sasaki T, Moriguchi M, Niwano H, Yoshimura H, Izumi T: Bepridil inhibits sub-acute phase of atrial electrical remodeling in canine rapid atrial stimulation model. Circ J 2006 70: 206 213.
27. Sakabe M, Fujiki A, Nishida K, Sugao M, Nagasawa H, Tsuneda T, Mizumaki K, Inoue H: Enalapril prevents perpetuation of atrial fibrillation by suppressing atrial fibrosis and over-expression of connexin43 in a canine model of atrial pacing-induced left ventricular dysfunction. J Cardiovasc Pharmacol 2004 43: 851 859.
28. Li D, Fareh S, Leung TK, Nattel S: Promotion of atrial fibrillation by heart failure in dogs: Atrial remodeling of a different sort. Circulation 1999 100: 87 95.
29. Li GR, Nattel S: Properties of human atrial ICa at physiological temperatures and relevance to action potential. Am J Physiol 1997 272: H227 235.
30. Brundel BJ, Van Gelder IC, Henning RH, Tieleman RG, Tuinenburg AE, Wietses M, Grandjean JG, Van Gilst WH, Crijns HJ: Ion channel remodeling is related to intraoperative atrial effective refractory periods in patients with paroxysmal and persistent atrial fibrillation. Circulation 2001 103: 684 690.
31. Brundel BJ, Ausma J, van Gelder IC, Van der Want JJ, van Gilst WH, Crijns HJ, Henning RH: Activation of proteolysis by calpains and structural changes in human paroxysmal and persistent atrial fibrillation. Cardiovasc Res 2002 54: 380 389.
32. Christ T, Boknik P, Wohrl S, Wettwer E, Graf EM, Bosch RF, Knaut M, Schmitz W, Ravens U, Dobrev D: L-type Ca2+ current downregulation in chronic human atrial fibrillation is associated with increased activity of protein phosphatases. Circulation 2004 110: 2651 2657.
33. Kneller J, Sun H, Leblanc N, Nattel S: Remodeling of Ca2+-handling by atrial tachycardia: Evidence for a role in loss of rate-adaptation. Cardiovasc Res 2002 54: 416 426.
34. Cha TJ, Ehrlich JR, Chartier D, Qi XY, Xiao L, Nattel S: Kir3-based inward rectifier potassium current: Potential role in atrial tachycardia remodeling effects on atrial repolarization and arrhythmias. Circulation 2006 113: 1730 1737.
35. Fareh S, Villemaire C, Nattel S: Importance of refractoriness heterogeneity in the enhanced vulnerability to atrial fibrillation induction caused by tachycardia-induced atrial electrical remodeling. Circulation 1998 98: 2202 2209.
36. Perelman MS, McKenna WJ, Rowland E, Krikler DM: A comparison of bepridil with amiodarone in the treatment of established atrial fibrillation. Br Heart J 1987 58: 339 344.
37. Yasuda M, Nakazato Y, Sasaki A, Kawano Y, Nakazato K, Tokano T, Daida H: Clinical evaluation of adverse effects during bepridil administration for atrial fibrillation and flutter. Circ J 2006 70: 662 666.